Calostyle 667 Tablet: A High-Demand Nephrology Product for Your PCD Pharma Franchise

The Essential Role of Phosphate Binders in Kidney Care

Understanding the Therapeutic Benefits of Calcium Acetate

Why Calostyle 667 is the Ideal Choice for Your B2B Pharma Portfolio

Quality, Efficacy, and Our Commitment to Your Success
How to Begin Your Monopoly Franchise with a Nephrology Product

Home/Products /calcium-acetate-667mg-tablet

Calostyle 667 Tablet

Composition : Calcium Acetate (667mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹132/-

In the critical and consistently high-demand field of nephrology, products that offer reliability and proven efficacy are essential. Calostyle 667 Tablet, with its Calcium Acetate (667mg) formulation, is a best-in-class phosphate binder for managing hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis. As a PCD pharma company, we recognize the consistent, high demand for such specialized products, making this a valuable asset for any pharma distributor or wholesaler.

Calcium Acetate is a highly effective phosphate binder that works in the gut to reduce the absorption of phosphate from food. Its well-established role in CKD management and its favorable safety profile make it a trusted choice for nephrologists and a stable, high-demand product for the market.

At Cafoli Lifecare, we are committed to providing our B2B pharma partners with high-quality, profitable products. Our Calostyle 667 Tablet is manufactured under strict quality controls and comes with a competitive pricing structure. By partnering with us, you gain access to a reliable supply of this essential medication and the comprehensive support needed to succeed in the wholesale pharma market. Choose this product to build a strong and reputable business in the cardiology segment.

Read More

About the Product

In the critical and consistently high-demand field of nephrology, products that offer reliability and proven efficacy are essential. Calostyle 667 Tablet, with its Calcium Acetate (667mg) formulation, is a best-in-class phosphate binder for managing hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis. As a PCD pharma company, we recognize the consistent, high demand for such specialized products, making this a valuable asset for any pharma distributor or wholesaler.

Calcium Acetate is a highly effective phosphate binder that works in the gut to reduce the absorption of phosphate from food. Its well-established role in CKD management and its favorable safety profile make it a trusted choice for nephrologists and a stable, high-demand product for the market.

At Cafoli Lifecare, we are committed to providing our B2B pharma partners with high-quality, profitable products. Our Calostyle 667 Tablet is manufactured under strict quality controls and comes with a competitive pricing structure. By partnering with us, you gain access to a reliable supply of this essential medication and the comprehensive support needed to succeed in the wholesale pharma market. Choose this product to build a strong and reputable business in the cardiology segment.

Common side effects may include nausea, abdominal discomfort, headache, and dizziness. Rarely, it may cause elevated liver enzymes or allergic reactions.

Italom 400 SR Tablet is indicated for the treatment of systemic and localized fungal infections, including aspergillosis, candidiasis, histoplasmosis, and onychomycosis.

Use only as directed by a healthcare provider. Avoid alcohol during treatment. Regular liver function monitoring is recommended for long-term use.

Store in a cool, dry place at a temperature below 30°C. Protect from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation